GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » SymBio Pharmaceuticals Ltd (TSE:4582) » Definitions » Shiller PE Ratio

SymBio Pharmaceuticals (TSE:4582) Shiller PE Ratio : (As of Jun. 01, 2024)


View and export this data going back to 2011. Start your Free Trial

What is SymBio Pharmaceuticals Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


SymBio Pharmaceuticals Shiller PE Ratio Historical Data

The historical data trend for SymBio Pharmaceuticals's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SymBio Pharmaceuticals Shiller PE Ratio Chart

SymBio Pharmaceuticals Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

SymBio Pharmaceuticals Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of SymBio Pharmaceuticals's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, SymBio Pharmaceuticals's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SymBio Pharmaceuticals's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, SymBio Pharmaceuticals's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where SymBio Pharmaceuticals's Shiller PE Ratio falls into.



SymBio Pharmaceuticals Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

SymBio Pharmaceuticals's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, SymBio Pharmaceuticals's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-18.03/107.2000*107.2000
=-18.030

Current CPI (Mar. 2024) = 107.2000.

SymBio Pharmaceuticals Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 -34.000 98.000 -37.192
201409 -29.800 98.500 -32.432
201412 -21.840 97.900 -23.915
201503 -51.920 97.900 -56.852
201506 -31.605 98.400 -34.431
201509 -47.320 98.500 -51.500
201512 -194.212 98.100 -212.228
201603 -80.600 97.900 -88.257
201606 -55.120 98.100 -60.233
201609 -70.720 98.000 -77.359
201612 -34.166 98.400 -37.221
201703 -48.480 98.100 -52.977
201706 -55.880 98.500 -60.816
201709 -186.200 98.800 -202.031
201712 -31.959 99.400 -34.467
201803 -53.120 99.200 -57.404
201806 -42.030 99.200 -45.420
201809 -30.080 99.900 -32.278
201812 -40.310 99.700 -43.342
201903 -29.920 99.700 -32.171
201906 -65.660 99.800 -70.529
201909 -65.750 100.100 -70.414
201912 -27.852 100.500 -29.709
202003 -35.840 100.300 -38.306
202006 -26.630 99.900 -28.576
202009 -23.008 99.900 -24.689
202012 -39.540 99.300 -42.686
202103 -5.490 99.900 -5.891
202106 0.107 99.500 0.115
202109 13.807 100.100 14.786
202112 43.960 100.100 47.078
202203 4.180 101.100 4.432
202206 24.140 101.800 25.421
202209 11.110 103.100 11.552
202212 -9.800 104.100 -10.092
202303 0.110 104.400 0.113
202306 -2.130 105.200 -2.170
202309 -17.870 106.200 -18.038
202312 -29.300 106.800 -29.410
202403 -18.030 107.200 -18.030

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


SymBio Pharmaceuticals  (TSE:4582) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


SymBio Pharmaceuticals Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of SymBio Pharmaceuticals's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


SymBio Pharmaceuticals (TSE:4582) Business Description

Traded in Other Exchanges
Address
5-23-7 Shimbashi, San-Ei Building, 8th Floor, Minato-ku, Tokyo, JPN, 105-0004
SymBio Pharmaceuticals Ltd is a biopharmaceutical company engaged in manufacturing and commercializing drugs for oncology, hematology, and pain management.

SymBio Pharmaceuticals (TSE:4582) Headlines

No Headlines